Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.

Ranolazine (Rn) is a drug used to treat persistent chronic coronary ischemia. It has also been shown to have therapeutic benefits on the central nervous system and an anti-diabetic effect by lowering blood glucose levels; however, no effects of Rn on cellular sensitivity to insulin (Ins) have been d...

Descripción completa

Detalles Bibliográficos
Autores: Jorda, A; Aldasoro, M; Campo-Palacio, I; Vila, JM; Aldasoro, C; Campos-Campos, J; Colmena, C; Singh, SK; Obrdor, E; Valles, SL
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2022
País:España
Institución:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p16937
Acceso en línea:https://incliva.portalinvestigacion.com/publicaciones/16937
Nivel de acceso:Acceso abierto
Palabra clave:antioxidants
astrocytes
inflammation
insulin
ranolazine
_version_ 1878736420109025280
author Jorda, A
author2 Aldasoro, M
Campo-Palacio, I
Vila, JM
Aldasoro, C
Campos-Campos, J
Colmena, C
Singh, SK
Obrdor, E
Valles, SL
author2_role author
author
author
author
author
author
author
author
author
author_browse Aldasoro, C
Aldasoro, M
Campo-Palacio, I
Campos-Campos, J
Colmena, C
Jorda, A
Obrdor, E
Singh, SK
Valles, SL
Vila, JM
author_facet Jorda, A
Aldasoro, M
Campo-Palacio, I
Vila, JM
Aldasoro, C
Campos-Campos, J
Colmena, C
Singh, SK
Obrdor, E
Valles, SL
author_role author
collection r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
description Ranolazine (Rn) is a drug used to treat persistent chronic coronary ischemia. It has also been shown to have therapeutic benefits on the central nervous system and an anti-diabetic effect by lowering blood glucose levels; however, no effects of Rn on cellular sensitivity to insulin (Ins) have been demonstrated yet. The present study aimed to investigate the permissive effects of Rn on the actions of Ins in astrocytes in primary culture. Ins (10(-8) M), Rn (10(-6) M), and Ins + Rn (10(-8) M and 10(-6) M, respectively) were added to astrocytes for 24 h. In comparison to control cells, Rn and/or Ins caused modifications in cell viability and proliferation. Rn increased protein expression of Cu/Zn-SOD and the pro-inflammatory protein COX-2 was upregulated by Ins. On the contrary, no significant changes were found in the protein expression of NF-?B and I?B. The presence of Rn produced an increase in p-ERK protein and a significant decrease in COX-2 protein expression. Furthermore, Rn significantly increased the effects of Ins on the expression of p-AKT, p-eNOS, p-ERK, Mn-SOD, and PPAR-?. In addition, Rn + Ins produced a significant decrease in COX-2 expression. In conclusion, Rn facilitated the effects of insulin on the p-AKT, p-eNOS, p-ERK, Mn-SOD, and PPAR-? signaling pathways, as well as on the anti-inflammatory and antioxidant effects of the hormone.
eu_rights_str_mv openAccess
format article
id ES_8eafebb5ac11140c510b8167f5dfce03
institution INCLIVA
instname_str INCLIVA
network_acronym_str ES
network_name_str España
oai_identifier_str oai:incliva.fundanetsuite.com:p16937
publishDate 2022
publishDateSort 2022
publisher MDPI
publisherStr MDPI
reponame_str r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
spelling Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture. Jorda, A Aldasoro, M Campo-Palacio, I Vila, JM Aldasoro, C Campos-Campos, J Colmena, C Singh, SK Obrdor, E Valles, SL antioxidants astrocytes inflammation insulin ranolazine Ranolazine (Rn) is a drug used to treat persistent chronic coronary ischemia. It has also been shown to have therapeutic benefits on the central nervous system and an anti-diabetic effect by lowering blood glucose levels; however, no effects of Rn on cellular sensitivity to insulin (Ins) have been demonstrated yet. The present study aimed to investigate the permissive effects of Rn on the actions of Ins in astrocytes in primary culture. Ins (10(-8) M), Rn (10(-6) M), and Ins + Rn (10(-8) M and 10(-6) M, respectively) were added to astrocytes for 24 h. In comparison to control cells, Rn and/or Ins caused modifications in cell viability and proliferation. Rn increased protein expression of Cu/Zn-SOD and the pro-inflammatory protein COX-2 was upregulated by Ins. On the contrary, no significant changes were found in the protein expression of NF-?B and I?B. The presence of Rn produced an increase in p-ERK protein and a significant decrease in COX-2 protein expression. Furthermore, Rn significantly increased the effects of Ins on the expression of p-AKT, p-eNOS, p-ERK, Mn-SOD, and PPAR-?. In addition, Rn + Ins produced a significant decrease in COX-2 expression. In conclusion, Rn facilitated the effects of insulin on the p-AKT, p-eNOS, p-ERK, Mn-SOD, and PPAR-? signaling pathways, as well as on the anti-inflammatory and antioxidant effects of the hormone. MDPI https://incliva.portalinvestigacion.com/publicaciones/16937
spellingShingle Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
Jorda, A
antioxidants
astrocytes
inflammation
insulin
ranolazine
status_str publishedVersion
title Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
title_full Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
title_fullStr Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
title_full_unstemmed Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
title_short Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
title_sort Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.
topic antioxidants
astrocytes
inflammation
insulin
ranolazine
topic_facet antioxidants
astrocytes
inflammation
insulin
ranolazine
url https://incliva.portalinvestigacion.com/publicaciones/16937